Phibro Animal Health Files 8-K Report
Ticker: PAHC · Form: 8-K · Filed: Nov 5, 2024 · CIK: 1069899
| Field | Detail |
|---|---|
| Company | Phibro Animal Health Corp (PAHC) |
| Form Type | 8-K |
| Filed Date | Nov 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $0.12 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
TL;DR
Phibro Animal Health filed an 8-K, expect updates on financials/operations.
AI Summary
On November 5, 2024, Phibro Animal Health Corporation filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and business operations. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing serves as an official notification to the SEC and investors about significant company events or financial updates. It ensures transparency and provides timely information for market participants.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain information suggesting immediate material risks.
Key Players & Entities
- Phibro Animal Health Corporation (company) — Registrant
- November 5, 2024 (date) — Report Date
- Delaware (jurisdiction) — State of Incorporation
- Teaneck, New Jersey (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Phibro Animal Health Corporation?
The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting "Other Events" and "Financial Statements and Exhibits" as of November 5, 2024.
When was the report filed and what is the earliest event date reported?
The report was filed on November 5, 2024, and the earliest event reported is also November 5, 2024.
In which state is Phibro Animal Health Corporation incorporated?
Phibro Animal Health Corporation is incorporated in Delaware.
What is the principal executive office address for Phibro Animal Health Corporation?
The principal executive offices are located at Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Boulevard, Suite 21, Teaneck, New Jersey 07666-6712.
What is the Standard Industrial Classification (SIC) code for Phibro Animal Health Corporation?
The SIC code for Phibro Animal Health Corporation is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-11-05 16:15:35
Key Financial Figures
- $0.0001 — ch registered Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Sto
- $0.12 — aration of a quarterly cash dividend of $0.12 per share on its Class A common stock a
Filing Documents
- tm2427470d1_8k.htm (8-K) — 26KB
- tm2427470d1_ex99-1.htm (EX-99.1) — 4KB
- tm2427470d1_ex99-1img01.jpg (GRAPHIC) — 7KB
- 0001104659-24-114319.txt ( ) — 210KB
- pahc-20241105.xsd (EX-101.SCH) — 3KB
- pahc-20241105_lab.xml (EX-101.LAB) — 33KB
- pahc-20241105_pre.xml (EX-101.PRE) — 22KB
- tm2427470d1_8k_htm.xml (XML) — 4KB
01
ITEM 8.01 OTHER EVENTS On November 5, 2024, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 18, 2024, to stockholders of record at the close of business on November 27, 2024. A copy of the press release announcing the dividend is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
FINANCIAL STATEMENTS AND EXHIBITS
FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated November 5, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PHIBRO ANIMAL HEALTH CORPORATION Registrant Date: November 5, 2024 By: /s/ Judith Weinstein Name: Judith Weinstein Title: Senior Vice President, General Counsel and Corporate Secretary